Sunshine Biopharma Files 8-K on Corporate Amendments
Ticker: SBFMW · Form: 8-K · Filed: Apr 23, 2024 · CIK: 1402328
| Field | Detail |
|---|---|
| Company | Sunshine Biopharma, Inc (SBFMW) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing, amendment
Related Tickers: SBFM
TL;DR
Sunshine Biopharma filed an 8-K on 4/23 for corporate changes on 4/17 related to stock and warrants.
AI Summary
Sunshine Biopharma, Inc. filed an 8-K on April 23, 2024, reporting an amendment to its articles of incorporation and the filing of exhibits. The report details events occurring on April 17, 2024, related to common stock and common stock purchase warrants. The company's fiscal year ends on December 31st.
Why It Matters
This filing indicates corporate housekeeping and potential adjustments to the company's capital structure, which could impact shareholders.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose significant new financial or operational risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the company's annual reporting cycle.)
Key Players & Entities
- Sunshine Biopharma, Inc. (company) — Registrant
- April 17, 2024 (date) — Date of earliest event reported
- April 23, 2024 (date) — Date of report
- Common Stock (security) — Subject of filing
- Common Stock Purchase Warrants (security) — Subject of filing
FAQ
What specific amendments were made to the articles of incorporation?
The filing indicates amendments were made but does not detail the specific changes within this summary section.
What is the significance of the common stock and common stock purchase warrants mentioned?
These are financial instruments related to the company's equity, and their mention suggests potential corporate actions or adjustments involving them.
What is the company's primary business sector?
Sunshine Biopharma, Inc. is in the Pharmaceutical Preparations sector (SIC code 2834).
When was the company incorporated or last changed its name?
The company was incorporated in Colorado and its name was last changed on October 30, 2007.
What is the filing date and the earliest event date reported?
The filing date is April 23, 2024, and the earliest event date reported is April 17, 2024.
Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2024-04-23 16:05:35
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value $0.001 SBFM The Nasdaq Stock Market LLC
Filing Documents
- sunshine_8k.htm (8-K) — 27KB
- sunshine_ex0301.htm (EX-3.1) — 15KB
- image_006.jpg (GRAPHIC) — 135KB
- image_007.jpg (GRAPHIC) — 44KB
- 0001683168-24-002616.txt ( ) — 505KB
- sbfm-20240417_def.xml (EX-101.DEF) — 26KB
- sbfm-20240417_lab.xml (EX-101.LAB) — 36KB
- sbfm-20240417_pre.xml (EX-101.PRE) — 25KB
- sbfm-20240417.xsd (EX-101.SCH) — 3KB
- sunshine_8k_htm.xml (XML) — 6KB
03 Amendments to Articles of Incorporation
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Effective April 17, 2024, Sunshine Biopharma, Inc. (the "Company") filed a certificate of amendment to its articles of incorporation with the Secretary of State of Colorado to effect a 1-for-100 reverse split of the Company's common stock.
01 Financial Statements
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Certificate of Amendment 104 Cover Page Interactive Data File (formatted in Inline XBRL). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 23, 2024 SUNSHINE BIOPHARMA, INC. By: /s/ Dr. Steve N. Slilaty Dr. Steve N. Slilaty, Chief Executive Officer 3